You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ALBENDAZOLE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for albendazole and what is the scope of freedom to operate?

Albendazole is the generic ingredient in two branded drugs marketed by Actavis Elizabeth, Alembic, Chartwell Rx, Cipla Ltd, Dr Reddys, Edenbridge Pharms, MSN, Strides Pharma, Zydus Pharms, and Impax Labs Inc, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for albendazole. Eighteen suppliers are listed for this compound.

Summary for ALBENDAZOLE
Drug Prices for ALBENDAZOLE

See drug prices for ALBENDAZOLE

Recent Clinical Trials for ALBENDAZOLE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Kintampo Health Research Centre, GhanaN/A
Public Health Laboratory Ivo de CarneriPhase 3
National Public Health Institute of LiberiaPhase 2

See all ALBENDAZOLE clinical trials

Pharmacology for ALBENDAZOLE
Drug ClassAnthelmintic
Mechanism of ActionCytochrome P450 1A Inducers
Medical Subject Heading (MeSH) Categories for ALBENDAZOLE

US Patents and Regulatory Information for ALBENDAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms ALBENDAZOLE albendazole TABLET;ORAL 208979-001 Dec 14, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Strides Pharma ALBENDAZOLE albendazole TABLET;ORAL 210011-001 Dec 7, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alembic ALBENDAZOLE albendazole TABLET;ORAL 215652-001 Sep 4, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Edenbridge Pharms ALBENDAZOLE albendazole TABLET;ORAL 211117-001 May 14, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Msn ALBENDAZOLE albendazole TABLET;ORAL 213435-001 Jan 21, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx ALBENDAZOLE albendazole TABLET;ORAL 211636-001 Jun 10, 2020 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.